John Hicks Co Ltd announces a new provision for clients in the centre of Cambridge.
John Hicks Co Ltd is now offering face to face consultations to clients within the heart of Cambridge.
Domino achieves Silver EcoVadis Rating
A Cambridge company has recently achieved a business sustainability rating for its corporate social responsibility performance.
Guardtech Group gearing up for busy Autumn exhibition schedule
Haverhill-based cleanroom construction specialists set to cover wide range of industries with stellar show line-up
Kuano raises £1.8M in seed funding to accelerate quantum drug discovery
Cambridge, UK, 12 September 2023: Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, announces the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other Angel investors. The investment will facilitate further validation of Kuano’s…
Career change - a setback or an opportunity?
Career change can be seen as a setback and at the same time it can also be an incredible opportunity to re-evaluate what it is you really want from your career. There are several reasons why you might be facing a career change – you may have been laid off, or you might feel unhappy in your current role, or perhaps you simply want to do something new.
Building a resilient system: operational ownership and observability at Gearset
Gearset writes...As part of our focus to deliver the leading Salesforce DevOps platform, we’re always looking for ways to improve our internal processes and continue to build a resilient system that serves our users. One of the ways we’re doing this is through our new observability team.
Orano Med and Orbit Discovery enter Collaboration to discover novel targeted radioligand therapies for cancer
Texas, US and Oxford, UK - Orano Med SAS, “Orano Med”, a biotechnology company developing Lead-212 (212Pb) Targeted Alpha Therapy against cancer, and Orbit Discovery Ltd, “Orbit”, a leader in the discovery of therapeutic peptide hits, announce that they have entered into a collaboration to discover specific Peptide Receptor Radionuclide Therapies against cancer cells and advance the development…
AudioTelligence launches crowdfunding campaign to meet demand for its hearing assistance device
AudioTelligence, a Cambridge audio software company, has launched a crowdfunding campaign in a bid to get its breakthrough hearing technology into the hands of those who struggle to hear in noisy environments.
Soft skills for hard impact: an introduction to Pincheck Ltd
An introduction to Pincheck Ltd by the Managing Director. Also features as a blog post on the Pincheck Ltd website.
The Space Age comes to the EpiCentre in Haverhill
The Space Age is coming to The EpiCentre in Haverhill on Wednesday 20th September 2023, and while the words “Houston, We have Lift Off” might send tingles down the spine, applications of the space industry have a much greater relevance to our everyday lives and businesses than we might realise.
Creative eating
Is there an ideal meal to catalyse your creativity? Maybe so, according to this experience…
Lessons for staying organised during creative development journeys
Sophie Baillie, Conscious Communications writes...
No-one said it would be easy
An article featured on the Pincheck Ltd blog, discussing the use of integrity and moral courage in addressing difficulties in leadership and management.
Weathering the inflation storm – the importance of a well-balanced and diversified portfolio
Just as a sudden squall can blow a ship off course, inflation can rapidly alter the direction of your investments.
Qkine partners with the UK’s new £12M cellular agriculture manufacturing hub, CARMA, to revolutionize sustainable food production
Qkine is excited to announce a new partnernship with the UK’s new £12M cellular agriculture manufacturing hub, CARMA. The EPSRC-funded Cellular Agriculture Manufacturing Hub will develop new approaches to making food products.
Express your tech: communicating your complex innovation
New event launched! Learn how to communicate your complex innovation to customers and investors at this Cambridge event.
Mills & Reeve advises on construction of advanced cancer research hospital
The Cambridge Cancer Research Hospital (CCRH) will be a 26,000m2 state of the art facility built in the heart of Cambridge.
Gosforth mum leads Great North Run campaign for children’s brain tumour charity
A Gosforth mum is leading a Great North Run campaign to support a children’s brain tumour charity after her son was diagnosed with a brain tumour.
All-inclusive service provided by the Epicentre, Haverhill allows universal genomics company MultiplAI to grow and move on
Its onwards and upwards for MultiplAI, a fast-expanding techbio company developing RNA-based, AI-driven, universal genomic screening for cardiovascular and other complex diseases, that has benefited from the flexible terms and business support offered by The EpiCentre in Haverhill.'
Domino makes major investment in Digital Printing division
A Cambridge company is making a number of significant investments in its Digital Printing division as part of a commitment to broadening the range of solutions for industries using labels and corrugated packaging. Domino Printing has established a dedicated 12,000 sq ft state-of-the-art training centre in the Gateway Building close to its Bar Hill headquarters to provide courses and resources…
The importance of Carbon Capture and Storage
There is currently a great deal of focus on Carbon Capture and Storage (CCS) as an effective means of limiting the damage caused by climate change. However, for the world to meet its 2050 net zero goals, up to 2 billion metric tonnes of carbon needs to be captured by 2030 – at present, global capture is just 43 million metric tonnes, or 0.1 % of global emissions. To ensure that the CCS…
Arecor announces positive pre-IND meeting with FDA for novel ready-to-use medicine AT307 licensed to Hikma
Cambridge, UK - Arecor, the biopharmaceutical group advancing today’s therapies to enable healthier lives, announces further progress from Hikma in the development of ready-to-use ("RTU") injectable medicine AT307, following a recent positive pre-investigational new drug application (pre-IND) meeting between Hikma and the US Food and Drug Administration (FDA).
It Takes a City report highlights - 'Being here has saved my life'
A short report highlights the power of partnership in action.